Frontiers in Genetics (Oct 2023)

Rational design of the genetic code expansion toolkit for in vivo encoding of D-amino acids

  • Han-Kai Jiang,
  • Han-Kai Jiang,
  • Han-Kai Jiang,
  • Jui-Hung Weng,
  • Yi-Hui Wang,
  • Yi-Hui Wang,
  • Jo-Chu Tsou,
  • Pei-Jung Chen,
  • Pei-Jung Chen,
  • An-Li Andrea Ko,
  • Dieter Söll,
  • Dieter Söll,
  • Ming-Daw Tsai,
  • Yane-Shih Wang,
  • Yane-Shih Wang,
  • Yane-Shih Wang

DOI
https://doi.org/10.3389/fgene.2023.1277489
Journal volume & issue
Vol. 14

Abstract

Read online

Once thought to be non-naturally occurring, D-amino acids (DAAs) have in recent years been revealed to play a wide range of physiological roles across the tree of life, including in human systems. Synthetic biologists have since exploited DAAs’ unique biophysical properties to generate peptides and proteins with novel or enhanced functions. However, while peptides and small proteins containing DAAs can be efficiently prepared in vitro, producing large-sized heterochiral proteins poses as a major challenge mainly due to absence of pre-existing DAA translational machinery and presence of endogenous chiral discriminators. Based on our previous work demonstrating pyrrolysyl-tRNA synthetase’s (PylRS’) remarkable substrate polyspecificity, this work attempts to increase PylRS’ ability in directly charging tRNAPyl with D-phenylalanine analogs (DFAs). We here report a novel, polyspecific Methanosarcina mazei PylRS mutant, DFRS2, capable of incorporating DFAs into proteins via ribosomal synthesis in vivo. To validate its utility, in vivo translational DAA substitution were performed in superfolder green fluorescent protein and human heavy chain ferritin, successfully altering both proteins’ physiochemical properties. Furthermore, aminoacylation kinetic assays further demonstrated aminoacylation of DFAs by DFRS2 in vitro.

Keywords